{"uri":"protocol-for-data-collection-on-drugs-use-in-inpat-iqqcdvw","version_id":"0","protocol_name":"Protocol for data collection on drugs use in inpatients","protocol_name_html":"Protocol for data collection on drugs use in inpatients","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"0","last_modified":"1510250179","type_id":"1","link":null,"fork_id":"","public_fork_note":"","number_of_steps":"0","has_versions":"0","first_published_date":"1498774501","publish_date":"2017-06-29 22:18:14","documents":"[{\"url\":\"https:\/\/s3.amazonaws.com\/pr-journal\/kytgw56.pdf\",\"file_id\":\"10961\",\"thumb_url\":\"\/img\/extensions\/pdf.png\",\"ofn\":\"Protocol for data collection on drugs use in inpatients.pdf\"}]","have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p>Forms used for data collection in the study entitled: \u201cRisk factors for adverse drug reactions in pediatric inpatients: a cohort study\u201d<\/p>\n<p>\u00a0<\/p>\n<p>Forms 1 and 2 must be used in the first pharmaceutical consultation after hospital admission of the patient:<\/p>\n<p>i) form 1 is aimed at obtaining information on the prior history of ADR of the patient; and<\/p>\n<p>ii) form 2 is aimed at obtaining information on the prior history of use of the drug.<\/p>\n<p>\u00a0<\/p>\n<p>Forms 3-6 must be used for the daily recording of information observed in medical prescriptions.<\/p>\n<p>i) form 3 is used to record potential drug interactions;<\/p>\n<p>ii) form 4 for registration of off-label drugs prescribed;<\/p>\n<p>iii) form 5 for the daily recording of the use of drugs; and<\/p>\n<p>iv) form 6 for daily monitoring of prescription errors<strong>.<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Furthermore, form 7 must be used for the registration of abnormal laboratory tests or other suspected adverse events.<\/p>\n<p>\u00a0<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"1","materials":[],"warning":"<p>Because this protocol deals with forms, no safet warnings\u00a0are required.<\/p>","version_class":"6640","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1499021605","protocol_affiliation":"Universidade Federal de Sergipe and Hospital Universit\u00e1rio de Sergipe","affiliation":"Universidade Federal de Sergipe","doi":"dx.doi.org\/10.17504\/protocols.io.iqqcdvw","doi_status":"2","changed_fork_steps":null,"profile_url":"PauloHenrique-x20354z2w2","protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/kyvgw56.png","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/kysgw56.jpg","full_name":"Paulo Henrique Santos Andrade","created_by":"Paulo Henrique Santos Andrade","private_link":"4FB2A8D65822C4935A785695DF63B718","original_img":"1","username":"paulo-henrique-santos-andrade","is_retracted":"0","retraction_reason":null,"plos_id":null,"manuscript_citation":"<p>Andrade PHS, Lobo IMF, da Silva\u00a0WB.\u00a0Protocol for data collection on drugs use in inpatients.\u00a0<em>protocols.io <\/em>2017. doi:\u00a0<a href=\"https:\/\/dx.doi.org\/10.17504\/protocols.io.iqqcdvw\" target=\"_blank\">dx.doi.org\/10.17504\/protocols.io.iqqcdvw<\/a><\/p>","journal_name":null,"is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":250781,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"Drug-Related Side Effects and Adverse Reactions, Hospitals, Inpatients","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[{"tag_id":"698","tag_name":"Adverse Drug Reaction"}],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"big_protocol_img":"https:\/\/s3.amazonaws.com\/pr-journal\/kyugw56.png","big_protocol_img_ofn":"ger\u00eancia de risco.png","is_locked":0,"is_locked_by":false,"authors":"Paulo Henrique Santos Andrade,Iza Maria Fraga Lobo,Wellington Barros da Silva","authors_list":[{"name":"Paulo Henrique Santos Andrade","affiliation":"Universidade Federal de Sergipe and Hospital Universit\u00e1rio de Sergipe","username":null,"profile_image":null},{"name":"Iza Maria Fraga Lobo","affiliation":"Universidade Federal de Sergipe and Hospital Universit\u00e1rio de Sergipe","username":null,"profile_image":null},{"name":"Wellington Barros da Silva","affiliation":"Universidade Federal de Sergipe and Hospital Universit\u00e1rio de Sergipe","username":null,"profile_image":null}],"user":{"profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/kysgw56.jpg","username":"paulo-henrique-santos-andrade","full_name":"Paulo Henrique Santos Andrade","created_by":"Paulo Henrique Santos Andrade"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":"<p>Forms 1 and 2 must be used in the first pharmaceutical consultation after hospital admission of the patient:<\/p>\n<p>i) form 1 is aimed at obtaining information on the prior history of ADR of the patient; and<\/p>\n<p>ii) form 2 is aimed at obtaining information on the prior history of use of the drug.<\/p>\n<p>\u00a0<\/p>\n<p>Forms 3-6 must be used for the daily recording of information observed in medical prescriptions.<\/p>\n<p>i) form 3 is used to record potential drug interactions;<\/p>\n<p>ii) form 4 for registration of off-label drugs prescribed;<\/p>\n<p>iii) form 5 for the daily recording of the use of drugs; and<\/p>\n<p>iv) form 6 for daily monitoring of prescription errors<strong>.<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Furthermore, form 7 must be used for the registration of abnormal laboratory tests or other suspected adverse events.<\/p>\n<p>\u00a0<\/p>","status_id":"1","is_research":"1","status_info":null,"steps":[]}